Additionally, cerebral VEGF overexpression within the AD brain has been linked to pericyte loss, capillary stalls, increases in BBB permeability, decreased CBF and increased AD pathology (Ali & Bracko, 2022; Mahoney et al., 2021), indicating a maladaptive overexpression. The gene discussed is VEGFA; the disease is Alzheimer disease.